(5-(Trifluoromethoxy)pyridin-2-yl)methanamine hydrochloride

Catalog No.: 
ACKGSV325
CAS No.: 
2044706-60-5
Molecular Formula: 
C7H8ClF3N2O
Molecular Weight: 
228.60
(5-(Trifluoromethoxy)pyridin-2-yl)methanamine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$262.00InquiryInquiry
100mg95%$391.00InquiryInquiry
250mg95%$958.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(5-(Trifluoromethoxy)pyridin-2-yl)methanamine hydrochloride
IUPAC Name(5-(trifluoromethoxy)pyridin-2-yl)methanamine hydrochloride
MDL No.MFCD30541493
Molecular FormulaC7H8ClF3N2O
Molecular Weight228.60
SMILESNCC1=NC=C(OC(F)(F)F)C=C1.[H]Cl
InChI KeyFYYLDSOMTOVBMI-UHFFFAOYSA-N
Synonym(5-(Trifluoromethoxy)pyridin-2-yl)methanamine hydrochloride;[5-(trifluoromethoxy)-2-pyridyl]methanamine;5-(Trifluoromethoxy)pyridine-2-methanamine Hydrochloride
CAS No.2044706-60-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACKGSV325 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  2. Plus
  3. ACRVZG528 route compound structure diagram
    ACRVZG52831191-05-6In Stock
  4. Then
  5. ACKGSV325 route product structure diagram
    ACKGSV3252044706-60-5
Inquiry

2. ACKGSV325 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKGSV325 route product structure diagram
    ACKGSV3252044706-60-5
Inquiry

3. ACKGSV325 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKGSV325 route product structure diagram
    ACKGSV3252044706-60-5
Inquiry

Comments (0)